NIDA Notice of Special Interest (NOSI)

Formerly known as Drug Abuse Topics of Special/Continuing Interest (DAT)

Important: Please contact the Program Official/Contact(s) before submitting an application.

A Notice of Special Interest (NOSI) is a new format for NIH Institutes/Centers to share and update their research priorities. NOSIs are intended to replace Program Announcements (PAs) that do not have special review criteria or set aside funds. Each NOSI describes aims in a specific scientific area(s) and points to Funding Opportunity Announcements (FOAs) through which investigators can apply for support.

Note that we continue to encourage investigator-initiated projects in topic areas not listed here, and that applications submitted in response to the relevant funding opportunities are NOT limited to the research and development areas described below.

This website only lists scientific/research topics and contacts and instructions for linking applications to specific topics of interest to NIDA (NOSIs). What is not included are additional application instructions, eligibility restrictions, review criteria, selection criteria, or other items related to the completeness or compliance of an application. These are found in the SF424 application guide.

Instructions for Submitting Applications:

For funding consideration, applicants must include “NOT-XX-XXX” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered as responding to a NOSI.

Topic Code Contacts

Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders (April 7, 2020)

NOT-DA-20-046 Roger G Sorensen, Ph.D., MPA
Ph: (301) 443-3205
Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes (March 25, 2020) NOT-DA-20-018 John Satterlee, Ph.D.
Ph: (301) 435-1020
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders (March 25, 2020) NOT-DA-20-021 Steven Grant, Ph.D.
Ph: (301) 443-8869
Notice of Special Interest (NOSI): Research Training and Career Development Awards to Support Individuals Pursuing Research Focused on Developing Treatments for Substance Use Disorders and the Associated Medical Consequences of these Disorders (March 24, 2020) NOT-DA-20-037 Guifang Lao, MD, Ph.D.
Ph: (301) 827-5931
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 19, 2020) NOT-DA-20-047 MeLisa Creamer, Ph.D., MPH
Ph: (301) 402-1933
Pam Fleming
Ph: (301) 480-1159
Ivan D. Montoya, M.D., M.P.H.
Ph: (301) 827-5936
Vasundhara Varthakavi, DVM, Ph.D.
Ph: (301) 443-2146
Roger Little, Ph.D.
Ph: (301) 435-1316
Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors (March 5, 2020) NOT-DA-20-017 Vani Pariyadath, Ph.D.
Ph: (301) 443-3209
Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders (March 5, 2020) NOT-DA-20-030 Jonathan D. Pollock, Ph.D.
Ph: (301) 435-1309

Notice of Special Interest (NOSI): Mentored Career Development Award in Large-Scale Clinical Study Development and Analysis (March 5, 2020)

NOT-DA-20-006 Vani Pariyadath, Ph.D.
Ph: (301) 443-3209
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (March 5, 2020) NOT-DA-20-039 Da-Yu Wu, Ph.D.
Ph: (301) 435-4649
Ann L. Anderson, MD, MPH
Ph: (301) 827-5916
Minki Chatterji, Ph.D.
Ph: (301) 827-5435
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders (March 3, 2020) NOT-DA-20-005 Vani Pariyadath, Ph.D.
Ph: (301) 443-3209
Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD (February 24, 2020) NOT-DA-20-020 Amy C. Lossie, Ph.D.
Ph: (301) 827-6092
Notice of Special Interest (NOSI): The HIV-HCV-Substance Use Disorder Syndemic: Therapeutic Approaches (February 21, 2020) NOT-DA-20-032 Raul Mandler, MD; FAAN; FANA
Ph: (301) 480-2541
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders (February 6, 2020) NOT-DA-20-013 Guifang Lao, MD, Ph.D.
Ph: (301) 827-5831
Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders (February 6, 2020) NOT-DA-20-031 John Satterlee, Ph.D.
Ph: (301) 435-1020
Notice of Special Interest(NOSI): HEAL Initiative: Social Network Analyses to Reduce American Indian and Alaska Native Opioid Use Disorder and Related Risks for Suicide and Mental Health Disorders (February 6, 2020) NOT-DA-20-033 Kathy Etz, Ph.D.
Ph: (301) 402-1749
Dawn Morales, Ph.D.
Ph: (301) 827-9668
Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction (January 06, 2020) NOT-DA-20-012 Tanya Ramey, MD, Ph.D.
Ph: (301) 827-5944
Kristopher Bough, Ph.D.
Ph: (301) 442-9800
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants (January 06, 2020) NOT-DA-20-007 Nathan M. Appel, Ph.D.
Ph: (301) 827-5918
Katrina Foster, Ph.D.
Ph: (301) 827-5815
Holly Moore, Ph.D.
Ph: (301) 827-7376

Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics (January 02, 2020)

Susan Wright, Ph.D.
Ph: (301) 402-6683
Peter Hartsock, Ph.D.
Ph: (301) 402-1964

Notice of Special Interest (NOSI): Epidemiology of Drug Abuse (August 29, 2019) NOT-DA-19-066 Marsha Lopez, Ph.D., MHS
Ph: (301) 402-1846
Notice of Special Interest (NOSI): Public Health Research on Cannabis (August 14, 2019) NOT-DA-19-065 Marsha Lopez, Ph.D., MHS
Ph: (301) 402-1846
Steve Gust, Ph.D.
Ph: (301) 402-1118
Heather Kimmel, Ph.D.
Ph: (301) 443-6504
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research (July 12, 2019) NOT-DA-19-041 Susan Wright, Ph.D.
Ph: (301) 402-6683
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction (July 11, 2019) NOT-DA-19-048 Amy B. Goldstein, Ph.D.
Ph: (301) 827-4124
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) (July 11, 2019) NOT-DA-19-037 Tisha Wiley, Ph.D.
Ph: (301) 594-4381
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) (July 11, 2019) NOT-DA-19-038 Naimah Weinberg, M.D.
Ph: (301) 443-6504
Amy C. Lossie, Ph.D.
Ph: (301) 827-6092